Overview

Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting

Status:
RECRUITING
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of realSKIN® to provide complete wound closure of mixed-depth, full-thickness burn wounds as an alternative treatment to autografting.
Phase:
PHASE3
Details
Lead Sponsor:
XenoTherapeutics, Inc.
Collaborator:
Joseph M. Still Research Foundation, Inc.